Sanofi SA

SNY · NYSE

$41.60−$0.36 (−0.86%)TodayMarket closed · Oct 23, 7:43 PM ET

Prev close $41.96

Latest news

Press releaseOct 20, 9:10 AM ETBusiness Wire
ScionxBio Announces Collaboration to Develop Long-Acting xRNA Therapeutics
NewsOct 19, 8:38 AM ETVandana Singh
Novavax's Second-Largest Shareholder Sells $32.6 Million in Stock, Ends Activist Push
NewsOct 16, 1:19 AM ETMohd Haider
Recursion Pharmaceuticals (RXRX) Stock is Trending After Hours: Here’s What You Should Know
NewsOct 15, 1:43 PM ETVandana Singh
Sanofi Must Set Record Straight on Rival Flu Shot Under EU Antitrust Deal
Press releaseOct 15, 12:00 PM ETPRNewswire
Sanofi and pCPA Sign Letter of Intent for Dupixent® Across Four Indications in Dermatology and Respiratory Care
Press releaseOct 14, 9:45 AM ETGlobe Newswire
AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test
Press releaseOct 2, 11:57 AM ETPRNewswire
Sanofi and 2026 NBA Champion Karl-Anthony Towns team up to raise awareness of COVID-19 vaccination with NUVAXOVID®
NewsOct 1, 11:07 AM ETVandana Singh
Sanofi Deepens 20-Year Drug Development Pact With Regeneron, Pledges Up to $8 Billion
NewsSep 18, 2:54 AM ET
Full Transcript: Sanofi Q2 2026 Earnings Call
NewsSep 16, 10:44 AM ETVandana Singh
Novo Nordisk, Anthropic Team Up For AI Drug Research
Press releaseSep 16, 10:30 AM ETPRNewswire
Sanofi inaugurates new flu vaccine facility, Canada's largest biomanufacturing investment
Press releaseSep 10, 9:05 AM ETPRNewswire
Sanofi partners with USA Pickleball to launch "Serve Up Protection" campaign to help protect older adults from COVID-19 with NUVAXOVID™
Press releaseSep 8, 8:30 AM ETGlobe Newswire
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
Press releaseSep 8, 8:00 AM ETPRNewswire
Sanofi and Keke Palmer team up to urge parents to help protect babies from serious RSV with BEYFORTUS®
NewsSep 1, 1:07 PM ETVandana Singh
The Multiple Sclerosis Drug Race Just Got Hotter After Novartis’ Phase 3 Win
NewsAug 27, 6:46 PM ET
QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax
NewsAug 24, 1:19 AM ETSnigdha Gairola
Dr. Oz Says The MMR Vaccine Is Not 'Lethal' as Trump Administration Faces Questions Over Vaccine Policy
NewsAug 18, 10:46 AM ETVandana Singh
European Medicines Agency Concerns Prompt Sanofi To Pull Dupixent Indication
NewsAug 10, 11:01 PM ETRadhika Anilkumar Nadig
Trump Cuts Core Childhood Vaccine Recommendations to 11, Bill Cassidy Says 'This Executive Order Is Wrong' (UPDATED)
NewsJul 30, 2:45 PM ETVandana Singh
Sanofi Says Weak Decision-Making Hurt Pipeline, Promises More Disciplined R&D
NewsJul 30, 1:34 AM ET
Sanofi Q2 Adj. EPS $1.21 Beats $1.09 Estimate, Sales $13.482B Beat $12.650B Estimate
NewsJul 24, 2:10 PM ETVandana Singh
Sanofi Drops Dupixent Successor Candidate After Assessing Data
NewsJul 16, 1:29 PM ETDaragh Thomas
Kalshi Will Let Traders Bet on FDA Drug Approvals Despite Critics' Insider Trading Warnings
NewsJul 10, 2:00 PM ETVandana Singh
Sanofi Wins FDA Approval for Wearable Injector Form of Blood Cancer Drug
NewsJul 8, 10:14 AM ETVandana Singh
Sino Biopharma Accelerates Global Growth With GSK, AstraZeneca Partnerships
NewsJun 30, 1:47 PM ETVandana Singh
Sanofi Reports Data From Nexviazyme Study, Says It Meets All Endpoints
NewsJun 29, 11:44 AM ETVandana Singh
EU Launches Antitrust Probe Into Sanofi Over Allegedly Misleading Flu Vaccine Claims (UPDATED)
NewsJun 23, 12:21 PM ETVandana Singh
Europe Approves Sanofi's Multiple Sclerosis Drug Despite FDA Rejection
NewsJun 22, 9:15 AM ETVandana Singh
AbbVie Expands Immunology Footprint With Apogee $11 Billion Acquisition
Press releaseJun 22, 8:30 AM ETGlobe Newswire
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
NewsJun 15, 1:15 PM ETVandana Singh
FDA OKs Sanofi Diabetes Drug In Newly Diagnosed Pediatric Patients
NewsJun 11, 9:09 AM ETVandana Singh
Sanofi Trial Setback May Reinforce Argenx Vyvgart's Position In CIDP, Analyst Says
NewsMar 9, 12:00 PM ET
P/E Ratio Insights for Sanofi
NewsDec 24, 11:06 AM ETAvi Kapoor
Dynavax Technologies, Omeros, Agios Pharmaceuticals, Nike And Other Big Stocks Moving Higher On Wednesday
Press releaseOct 2, 8:00 AM ETBusiness Wire
Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes
NewsSep 4, 8:17 AM ETAvi Kapoor
C3.ai Posts Downbeat Results, Joins GitLab, Salesforce And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Press releaseMay 21, 7:30 PM ETGlobe Newswire
Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi
NewsMay 21, 10:00 AM ET
Price Over Earnings Overview: Sanofi
NewsDec 25, 8:15 AM ET
A Look Into Sanofi Inc's Price Over Earnings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

ScionxBio Announces Collaboration to Develop Long-Acting xRNA Therapeutics

Novavax's Second-Largest Shareholder Sells $32.6 Million in Stock, Ends Activist Push

Recursion Pharmaceuticals (RXRX) Stock is Trending After Hours: Here’s What You Should Know

Sanofi Must Set Record Straight on Rival Flu Shot Under EU Antitrust Deal

Sanofi and pCPA Sign Letter of Intent for Dupixent® Across Four Indications in Dermatology and Respiratory Care

AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test

Sanofi and 2026 NBA Champion Karl-Anthony Towns team up to raise awareness of COVID-19 vaccination with NUVAXOVID®

Sanofi Deepens 20-Year Drug Development Pact With Regeneron, Pledges Up to $8 Billion

Full Transcript: Sanofi Q2 2026 Earnings Call

Novo Nordisk, Anthropic Team Up For AI Drug Research

Sanofi inaugurates new flu vaccine facility, Canada's largest biomanufacturing investment

Sanofi partners with USA Pickleball to launch "Serve Up Protection" campaign to help protect older adults from COVID-19 with NUVAXOVID™

A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach

Sanofi and Keke Palmer team up to urge parents to help protect babies from serious RSV with BEYFORTUS®

The Multiple Sclerosis Drug Race Just Got Hotter After Novartis’ Phase 3 Win

QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax

Dr. Oz Says The MMR Vaccine Is Not 'Lethal' as Trump Administration Faces Questions Over Vaccine Policy

European Medicines Agency Concerns Prompt Sanofi To Pull Dupixent Indication

Trump Cuts Core Childhood Vaccine Recommendations to 11, Bill Cassidy Says 'This Executive Order Is Wrong' (UPDATED)

Sanofi Says Weak Decision-Making Hurt Pipeline, Promises More Disciplined R&D

Sanofi Q2 Adj. EPS $1.21 Beats $1.09 Estimate, Sales $13.482B Beat $12.650B Estimate

Sanofi Drops Dupixent Successor Candidate After Assessing Data

Kalshi Will Let Traders Bet on FDA Drug Approvals Despite Critics' Insider Trading Warnings

Sanofi Wins FDA Approval for Wearable Injector Form of Blood Cancer Drug

Sino Biopharma Accelerates Global Growth With GSK, AstraZeneca Partnerships

Sanofi Reports Data From Nexviazyme Study, Says It Meets All Endpoints

EU Launches Antitrust Probe Into Sanofi Over Allegedly Misleading Flu Vaccine Claims (UPDATED)

Europe Approves Sanofi's Multiple Sclerosis Drug Despite FDA Rejection

AbbVie Expands Immunology Footprint With Apogee $11 Billion Acquisition

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis

FDA OKs Sanofi Diabetes Drug In Newly Diagnosed Pediatric Patients

Sanofi Trial Setback May Reinforce Argenx Vyvgart's Position In CIDP, Analyst Says

P/E Ratio Insights for Sanofi

Dynavax Technologies, Omeros, Agios Pharmaceuticals, Nike And Other Big Stocks Moving Higher On Wednesday

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

C3.ai Posts Downbeat Results, Joins GitLab, Salesforce And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi

Price Over Earnings Overview: Sanofi

A Look Into Sanofi Inc's Price Over Earnings